Washington’s hepatitis C elimination initiative expanded access to testing and treatment while reducing per-patient costs, UW-led study finds | UW News
Hepatitis C (HCV) is the most common bloodborne illness in the United States, and disproportionately impacts low-income people and marginalized communities. A recent UW study evaluates the first-in-the-nation plan for coordination between public health agencies, increased screening, removal of barriers to care and a new approach to purchasing HCV antiviral medications at a discount. DGH professor Dr. Pamela Kohler is quoted.







